NDC 64764-080
Amitiza 8 ug capsule, gelatin coated
On the label: Takeda Pharmaceuticals America, Inc..
Where it's made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Takeda Pharmaceuticals America, Inc. names for other drugs.
Recalls
- May 13, 2019 · Class II · Mallinckrodt Pharmaceuticals
Labeling: Label mix-up. Amitiza 8 mcg capsules are being recalled because 24 mcg capsules were found in a 8 mcg trade 60 ct. bottle. Amitiza 24 mcg capsules are being recalled because a sealed 60 ct. bottle contained only 8 mcg capsules, this incident is being considered as a labeling mix-up issue.
Lots: Lot #: 3229691-61, Exp 01/2022 - May 13, 2019 · Class II · Mallinckrodt Pharmaceuticals
Labeling: Label mix-up. Amitiza 8 mcg capsules are being recalled because 24 mcg capsules were found in a 8 mcg trade 60 ct. bottle. Amitiza 24 mcg capsules are being recalled because a sealed 60 ct. bottle contained only 8 mcg capsules, this incident is being considered as a labeling mix-up issue.
Lots: Lot #: 3200626-61, Exp 02/2022 - Nov 6, 2018 · Class III · Takeda Development Center Americas, Inc.
Failed Impurities/Degradation Specifications:Elevated levels of a known impurity in the 20-month stability sample testing.
Lots: Lot # 3098628-61, exp. date 02/28/2021
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Lubiprostone: every company that makes it
- Form
- capsule, gelatin coated, oral
- Strength
- 8 ug
- Approval
- NDA NDA021908
- On the market since
- Jan 31, 2006
- Package NDCs
64764-080-4064764-080-60- Official label
- DailyMed (National Library of Medicine), updated Jan 18, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?